By Jacquelyn Gray
Researchers have manufactured a peptide aimed to block modified proteins associated with Alzheimer’s disease, Parkinson’s disease, heart disease, Type 2 diabetes, Lou Gehrig’s disease, and other conditions.
By Rachel Lutz
Diabetic neuropathic pain can be controlled with a low-fat vegan diet, according to research presented at the American Association of Diabetic Educators Annual Meeting.
Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of Clinical Oncology.
By Jeannette Wick
Patients diagnosed with thyroid disease often use it as an explanation or excuse for neuropsychiatric symptoms; this is a form of “labeling effect.”
The association between obesity and subsequent dementia varies with the age at which obesity is first recorded, according to a study published online Aug. 20 in the Postgraduate Medical Journal.
By Adam Hochron
The US Food and Drug Administration recently announced the approval of the KRONUS Zinc Transporter 8 Autoantibody (ZnT8Ab) ELISA Assay, a new test for type 1 diabetes.
A defined process is necessary to help physicians hire the right staff for their practice, according to an article published July 24 in Medical Economics.
Pistachio consumption is associated with improvements in glucose and cardiometabolic parameters, according to a study published online Aug. 14 in Diabetes Care.
Physicians and health care providers must be aware of their potential liability when ordering screening tests, according to an article published July 24 in Medical Economics.
By Adam Hochron
Every year, more and more Americans are diagnosed with type 2 diabetes mellitus and, according to a recent study, in the near future that number could reach close to 40% of the population.